ESCC demonstrates significantly upregulated expression of tryptophan 2,3-dioxygnease 2 (TDO2), inducing M2 macrophage polarization through the activation of the AKT/GSK3 signaling pathway and upregulation of IL-1β (35). The gene discussed is IL1B; the disease is esophageal squamous cell carcinoma.